收稿日期: 2020-04-16
修回日期: 2020-04-29
网络出版日期: 2020-06-26
基金资助
上海市申康临床技能与临床创新三年行动计划(16CR1007A);上海交通大学医学院附属第九人民医院临床研究助推计划(“临+计划”JYLJ001);上海交通大学医学院附属第九人民医院生物样本库专项基金(YBKA201902);上海交通大学医学院附属第九人民医院临床研究型MDT项目(201701001)
Case Report: Clinical Attempt of Targeted Therapy for Complex Venous Malformations
Received date: 2020-04-16
Revised date: 2020-04-29
Online published: 2020-06-26
刘泓源, 杨希, 顾豪, 胡丽, 孙怡, 陈辉, 林晓曦 . 1例复杂静脉畸形的靶向治疗[J]. 组织工程与重建外科杂志, 2020 , 16(3) : 198 -200 . DOI: 10.3969/j.issn.1673-0364.2020.03.006
Key words: Venous malformation; Sirolimus; Vascular malformation; Target therapy
[1] | 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019,15(5):277-317. |
[2] | Freixo C, Ferreira V, Martins J , et al. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review[J]. J Vasc Surg, 2020,71(1):318-327. |
[3] | Soblet J, Kangas J, Natynki M , et al. Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations[J]. J Invest Dermatol, 2017,137(1):207-216. |
[4] | Castel P, Carmona FJ, Grego-Bessa J , et al. Somatic PIK3CA mutations as a driver of sporadic venous malformations[J]. Sci Transl Med, 2016, 8(332):332ra42. |
[5] | Adams DM, Trenor CC 3rd, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies[J]. Pediatrics, 2016,137(2):e20153257. |
[6] | Hammer J, Seront E, Duez S , et al. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study[J]. Orphanet J Rare Dis, 2018,13(1):191. |
[7] | Hammill AM, Wentzel M, Gupta A , et al. Sirolimus for the treatment of complicated vascular anomalies in children[J]. Pediatr Blood Cancer, 2011,57(6):1018-1024. |
[8] | Lackner H, Karastaneva A, Schwinger W , et al. Sirolimus for the treatment of children with various complicated vascular anomalies[J]. Eur J Pediatr, 2015,174(12):1579-1584. |
[9] | Morelon E, Stern M, Israel-Biet D , et al. Characteristics of sirolimus-associated interstitial pneumonitis in renal transplant patients[J]. Transplantation, 2001,72(5):787-790. |
[10] | Russell TB, Rinker EK, Dillingham CS , et al. Pneumocystis jirovecii pneumonia during sirolimus therapy for kaposiform hemangioendo the lioma[J]. Pediatrics, 2018,141(Suppl 5):S421-S424. |
[11] | Fujii T, Shimono R, Tanaka A , et al. A case of suspected adverse reactions to sirolimus in the treatment of generalized lymphatic anomaly[J]. Case Rep Pediatr, 2019,2019:3101357. |
[12] | Ying H, Qiao C, Yang X , et al. A case report of 2 sirolimus-related deaths among infants with kaposiform hemangioendotheliomas[J]. Pediatrics, 2018,141(Suppl 5):S425-S429. |
[13] | Goldenberg DC, Carvas M, Adams D , et al. Successful treatment of a complex vascular malformation with sirolimus and surgical resection[J]. J Pediatr Hematol Oncol, 2017,39(4):e191-e195. |
/
〈 |
|
〉 |